Alle Insider-Transaktionen auf den wichtigsten Aktienmärkten
Hält derzeit Positionen bei TuHURA Biosciences Inc, Heron Therapeutics Inc, TuHURA Biosciences Inc, CombiMatrix Corp and Kura Oncology Inc
| 30 Tage | Letzte 90 Tage | 120 Tage | |
|---|---|---|---|
| Durchschnittliche Rendite | -23% | 8.2% | 15.1% |
| Erfolgsquote | 0% | 68% | 82% |
| Transaktionen |
1
100% Kauf
|
34
71% Kauf
|
47
69% Kauf
|
| Position | Unternehmen | Zeitraum |
|---|---|---|
| Chairman of the Board | TuHURA Biosciences Inc | 2. Juni 2018 - |
| Chief Financial Officer, Senior Vice President - Finance | Heron Therapeutics Inc | 1. April 2017 - |
| Independent Chairman of the Board | TuHURA Biosciences Inc | 2. Juni 2018 - |
| Independent Director | CombiMatrix Corp | 15. Juli 2013 - |
| Independent Director | Kura Oncology Inc | 1. März 2015 - |
| Independent Director | Aravive Inc | 12. Oktober 2018 - 8. April 2020 |
| Independent Director | TuHURA Biosciences Inc | None - |
| Independent Director | MabVax Therapeutics Holdings Inc | 8. September 2014 - 31. Dezember 2017 |
| Chief Financial Officer, Executive Vice President, Principal Accounting Officer | Innovus Pharmaceuticals Inc | 6. September 2016 - 21. April 2017 |
| Chief Financial Officer, Senior Vice President - Finance | Arena Pharmaceuticals Inc | 15. Juni 2012 - 10. Juli 2015 |
| Chief Financial Officer, Vice President - Finance | Arena Pharmaceuticals Inc | 29. August 2011 - 15. Juni 2012 |